My lab is blessed to have the latest MARS photon-counting micro-CT scanner. This spectral (multi-energy) CT will be used for preclinical research and development and translation to clinical applications such as targeted nanoparticle imaging and quantitative molecular imaging.
The MARS system is the only product in the market that enables important investigations with photon-counting detectors and redefines the state of the art.
Our research horizons keep expanding as we learn more possibilities enabled by our MARS photon-counting micro-CT: from living histology to measuring drug delivery. Using a new cutting-edge molecular imaging technology that is also quantitative has meant we are sought after as research partners by local and international collaborators.
Our grant funding success rate has increased. This is because we have the opportunity to make novel advances towards answering hitherto unsolved medical research questions. The non-destructive methodology used for these advances made in the laboratory is designed for translation to human imaging.
My lab is pleased to feature the MARS photon-counting micro-CT in our research and development of targeted nanoparticle imaging probes for contrast-enhanced CT and quantitative molecular imaging with spectral (multi-energy) CT.
The MARS system is the only product on the market that enables my cutting-edge research to move forward as fast as possible. We are able to transition seamlessly between translation studies spanning from imaging phantoms to in vivo murine models.